Monday, 31 August 2026European Markets
ExploreSearch
ViaNews EU
stockMarket

PHAROL Stock Impressive Rise On Thursday, Outperforms Market

Loading stream...

(VIANEWS) - The Market ended the session with PHAROL (PHR.LS) jumping 12.32% to €0.05 on Thursday while PSI dropped 0.19% to €6,589.57.

PHAROL's last close was €0.04, 46.45% under its 52-week high of €0.08.

About PHAROL

Pharol, SGPS S.A., through its investment in Oi, S.A., provides telecommunications services in Brazil. The company was formerly known as Portugal Telecom, SGPS, SA and changed its name to Pharol, SGPS S.A. in May 2015. Pharol, SGPS S.A. was incorporated in 1994 and is headquartered in Lisbon, Portugal.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -3.04%.

Volatility

PHAROL's last week, last month's, and last quarter's current intraday variation average was 3.57%, 0.24%, and 1.43%.

PHAROL's highest amplitude of average volatility was 3.57% (last week), 1.97% (last month), and 1.43% (last quarter).

More news about PHAROL (PHR.LS).

Categories

stockMarket

Tags

Market-Close NowStock PriceClosesPHAROLStock Market NowEnd of DayPrice UpPHR.LSMarket CloseStock Price UpStock MarketStock
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com